Takeda sells Japan’s non-core products portfolio to Teijin Pharma
Takeda Pharmaceutical has completed the asset transfer linked to a portfolio of select non-core products in Japan to Teijin Pharma…
Latest Metabolic Disorders
-
1 week
-
1 month
-
4 months
-
5 months
-
1 week
-
1 month
-
4 months
-
5 months
Takeda to sell diabetes products portfolio to Teijin Pharma for $1.25bn
Takeda Pharmaceutical Company has signed an agreement to sell four non-core type 2 diabetes products in Japan to Teijin Pharma…
Latest News
View More
Novo Nordisk’s Saxenda not recommended for NHS use
The UK’s National Institute for Health and Care Excellence (NICE) has decided to not recommend National Health Service (NHS) use of Novo Nordisk’s Saxenda (liraglutide). Saxenda…
Novo Nordisk secures FDA expanded indication for Ozempic
The US Food and Drug Administration (FDA) has approved a new indication for Novo Nordisk’s Ozempic (semaglutide). The once-weekly injection is now indicated to reduce…
MiNA Therapeutics, AstraZeneca partner for metabolic diseases
UK-based MiNA Therapeutics has entered into a research collaboration agreement with AstraZeneca to assess small activating RNA (saRNA) molecules in…
Galen acquires Nordic-based POA Pharma in multi-million pound deal
Northern Ireland-based, globally focused pharmaceutical sales and marketing firm Galen has acquired Swedish-headquartered POA Pharma in a multi-million pound takeover…
FDA approves Novo Nordisk’s Fiasp for diabetic children
Danish pharmaceutical company Novo Nordisk has secured US Food and Drug Administration (FDA) approval for Fiasp as a mealtime insulin…
WHO announces pilot for insulin prequalification
The World Health Organization (WHO) has launched a pilot programme for insulin prequalification to boost access to diabetes treatment. Under…
Company A-Z
View More
Rheo Engineering
Material Handling Products and Turnkey Process Systems for Pharmaceutical Applications
Latest Content
View More
Takeda bets on Engitix’s ECM drug discovery platform for liver fibrosis
London-headquartered Engitix is partnering with pharma giant Takeda to discover and develop novel therapies for advanced fibrotic liver diseases, including…
Novo Nordisk moves further into CV diseases with Corvidia acquisition
Danish pharma company Novo Nordisk has entered a definitive agreement to acquire Massachusetts-headquartered Corvidia Therapeutics. The deal involves an upfront…
Five Reasons to Invest in Digital Inspection Workflow Execution in the Life Science Industry
The benefits of digital inspection workflow execution in pharma, biotech and medical device manufacturing go far beyond perfect compliance and…
Five Must-Have Features for Digital Instructions in the Life Science Industry
To handle typical process complexity challenges in pharma, biotechnology or medical device manufacturing, the solution you choose must be robust…
GDN Water Treatment
GDN Water Treatment has more than 40 years of experience in the manufacture of the most advanced water treatment plants…
Origin Announces Significant Expansion to Warehouse and Logistics Facilities
Origin Pharma Packaging has opened a new warehouse facility in Scunthorpe, North Lincolnshire, expanding on its logistics and storage site…